MN-001
Idiopathic Pulmonary Fibrosis · Novel Therapy
Clinical trials
1
Mechanism
Novel Therapy
Developer
MediciNova
Overview
MN-001 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via novel therapy. It appears in 1 tracked IPF clinical trial.
MN-001 clinical trials
Explore related
Medical disclaimer. This page summarizes research about MN-001 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.